International Eurasian Hematology Congress
Transkript
International Eurasian Hematology Congress
Hematology Specialists Association Meetings and Congresses [email protected] www.hematology.org.tr Hematology Specialists Association Executive Committee President Prof. Suleyman Dincer, MD Hisar Intercontinental Hospital, Istanbul Secretary Prof. Birol Guvenc, MD Cukurova University, Adana Member Prof. Serdar Bedii Omay, MD Mardin Artuklu University, Mardin Member Prof. Ayşen Timuragaoglu, MD Emsey Hospital, Istanbul Member Prof. Orhan Ayyildiz, MD Dicle University, Diyarbakir Member Prof. Sehmuz Ertop, MD Bulent Ecevit University, Zonguldak Member Prof. Salih Aksu, MD Hacettepe University, Ankara 1 Mission and Goals Mission Hematology Specialists Association (HSA) is a non-profit organization for both clinicians and scientists devoted to the scientific, medical, practical, technical, administrative, and educational aspects of Hematology in Turkey and beyond. By providing educational and training opportunities, the HSA contributes towards improving the health of patients suffering from blood diseases. Goals Hematology Specialists Association aims; • to provide educational and training opportunities for the clinicians and scientist working in the field of hematology, • to create a collaborative network made up of associations, institutions, clinicians, scientists, and nurses willing to share their experience and knowledge, • to spread the information about the most recent developments in hematology, • to provide educational materials and resources to people and their relatives affected by hematologic disorders, • to improve the quality of patient care in hematology in Turkey and beyond, • to represent Turkish Hematology at the international level. 2 Content Partners MDS Foundation Leukemia&Lymphoma Society American Cancer Society International Myeloma Foundation National Marrow Donor Program Kyrgyzstan Hematology Institute Uzbekistan Hematology Institute Azerbaijan Hematology Institute 3 International Eurasian Hematology Congress HSA has been annually organizing the International Eurasian Hematology Congress, one of the largest medical meetings in Turkey since 2010. The International Eurasian Hematology Congress is a scientific event providing latest developments on clinical and experimental researches in hematologic disorders and establishing an international collaborative network of medical professionals. The 5th International Eurasian Hematology Congress was held with great success on 15-19 October, 2014, in Antalya, Turkey. This event attracted over 800 delegates, 300 of them from 34 different countries. Sixty five world known speakers presented their latest research findings and perspectives on the hematologic diseases. All delegates had opportunity to participate in group discussions and share their ideas and experiences. Moreover, a number of selected abstracts were published in the supplement of Leukemia Research journal. 4 Invitation to the 6th International Eurasian Hematology Congress Dear Colleagues, I would like to draw your attention to the 6th International Eurasian Hematology Congress which will take place in Antalya, Turkey on 14-18, October, 2015. This extraordinary event will provide educational lectures in the field of hematology, focusing on practical treatment and case studies. Major emphasis will be given to new therapeutics, diagnosis and management of high risk patients. The speakers are internationally recognized experts in the field of hematology and will be also available for group discussions and workshops during the meeting. Additionally, debate sessions will highlight topics that are currently controversial. Turkey is a place where East meets West, so this congress inspires and creates a wide collaborative network of clinicians and scientists from all over the world. The congress will be held in Antalya, the fourth biggest touristic center of the world, one of the most beautiful cities of Turkey, with its magnificent nature, entertainment centers, sport and culture activities, awarded beaches, and beautiful sea. Don’t miss this unique opportunity! Further details can be found at: www.hematology.org.tr Yours sincerely, Prof. Suleyman DINCER , MD Prof. Giuseppe SAGLIO , MD Prof. Birol GUVENC , MD President of HSA Congress President Secretary of HSA 5 6 Past Meetings V. International Eurasian Hematology Congress 15-19 October 2014 Mardan Palace- Kundu / Antalya IV. International Eurasian Hematology Congress 09-13 October 2013 Mardan Palace- Kundu / Antalya III. International Eurasian Hematology Congress 17-21 October 2012 Mardan Palace- Kundu / Antalya II. International Eurasian Hematology Congress 13-16 October 2011 Mardan Palace- Kundu / Antalya I. International Eurasian Hematology Congress 7-10 October 2010 Maritim Pine Beach Resort- Belek / Antalya 7 8 V. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS PROGRAM 15-19 OCTOBER 2014 15 October 2014 Wednesday 16:00-16:30 Opening Speech Dr. Suleyman Dincer Specific Lectures CML: How do We Have to Treat our CML Patients in the Era of Genetic Imatinib? How Should We Treat Hodgkin Lymphoma? Moderators: Dr. Salih Aksu, Dr. Cengiz Beyan, Dr. Oktay Bilgir Dr. Hagop Kantarjian 17:00-17:30 The Essential Management of AML Dr. Alan Burnett 17:30-18:00 The Essential Management of Adult ALL Dr. Dieter Hoelzer 18:00-18:30 Next Generation Micro-Analysis and Diagnosis Using Computational Imaging, Crowd-sourcing and Gaming 18:30-19:00 Radiation and Leukemias How Should We Treat MDS? 10:30-10:45 Open Coffee Break and Discussion with the Speakers Moderators: Dr. Birol Guvenc, Dr. Giuseppe Saglio 16:30-17:00 16 October 2014 Thursday Moderators: Dr. Serdar Bedii Omay, Dr. Mustafa Solak, Dr. Duzgun Ozatli Myelodysplastic Syndromes: Old and New Classifications 09:00-09:30 Dr. Peter Greenberg and Prognostic Scores Dr. Giullermo Garcia 09:30-10:00 Molecular Alterations of MDS Manero 10:00-10:30 Standard Treatment of MDS Including Transplant Dr. Elias Jabbour Dr. Aydogan Ozcan Dr. Robert Gale 19:00-20:00 Welcome Cocktail 10:45-11:15 Diagnosis and Staging First-line Therapy, Evaluation of Response and Second 11:15-11:45 Line Therapy 11:45-12:45 Lunch Break Dr. Evren Ozdemir Dr. Alessandro Levis Specific Lectures Moderators: Dr. Osman Ilhan, Dr. Vahap Okan 12:45-13:15 ECP for Certain Transplant Rejection Dr. Claudia Del Fante 13:15-13:45 Iron Metabolism: New Horizon Dr. Hanan Hamed 13:45-14:15 Graft Engineering to Prevent Viral Infection Dr. Francesco Saglio The Future: New Targets for Therapy of Hematological Malignancies - 1 Moderators: Dr. Filiz Vural, Dr. Tulin Tuglular Firatli 14:15-14:45 New Targets in ALL Dr. Sabina Chiaretti 14:45-15:15 New Targets in AML: Only for Minimal Residual Disease? Dr. Mehmet Yilmaz Products Situation of the Biosimilar in Turkey and in the 15:15-15:45 Dr. Alper Iskit World 15:45-16:00 Open Coffee Break and Discussion with the Speakers The Future: New Targets for Therapy of Hematological Malignancies - 2 Moderators: Dr. Sehmuz Ertop, Dr. Hakan Goker, Dr. Mehmet Turgut 16:00-16:30 New Targets in MPNs New Indications for Old Antibodies: HUS / PNH: A Model 16:30-17:00 Disease Infections in Hematology Dr. Tariq Mughal Dr. Igor Lisukov Moderators: Dr. Aysen Timuragaoglu, Dr. Nilgun Sayinalp 17:00-17:30 IFI Management: Putting Theory into Practice Dr. Samir Agrawal 17:30-18:00 New Antibiotic Strategy in Neutropenia Prophylactic Anti Fungal Treatment in Hematologic 18:00-18:30 Malignancies Dr. Omrum Uzun 17 October 2014 Friday Dr. Esin Senol 18 October 2014 Saturday How to Manage Chronic Lymphoid Leukemias Moderators: Dr. Orhan Ayyildiz, Dr. Oral Nevruz, Dr. Ahmet İfran Stem Cell Transplant - 1 Moderators: Dr. Suleyman Dincer, Dr. Deniz Sargin, Dr. Yener Koc 09:00-09:30 Current and Evolving Therapy of CLL Dr. Susan O’ Brien 09:30-10:00 Chimeric Antigen Receptor T Cells for Treatment of CLL Dr. J. Joseph Melenhorst 09:00-09:30 CAR T-Cell Therapy Dr. Hanan Hamed 09:30-10:00 Transplant in Thalassemia: an Update Dr. Federica Pilo 10:00-10:30 What is Essential to Know About Stem Cells Dr. Albert Donnenberg 10:00-10:15 Open Coffee Break and Discussion with the Speakers How to Manage Chronic Myeloid Leukemias and MPNs 10:30-10:45 Open Coffee Break and Discussion with the Speakers Moderators: Dr. Selim Yavuz, Dr. Guray Saydam Non-Hodgkin Lymphoma 10:15-10:45 CML Response Monitoring in 2014 Dr. Naeem Chaudrhi 10:45-11:15 How I Treat Essential Thrombocythemia Dr. Jiri Schwarz Moderators: Dr. Mustafa Cetin, Dr. Mehmet Dagli, Dr. Hakan Akbulut 11:15-11:45 How I Manage PV Dr. Petro Petrides 10:45-11:15 How I Manage Indolent Non-Hogkin Lymphoma Dr. Berksoy Sahin 11:15-11:45 How I Manage Mantle Cell Lymphoma Dr. Carmino De Souza 11:45-12:15 How I Manage DLBCLs Cell Lymphoma Dr. Khaled Halahleh 11:45-12:45 Lunch Break How to Treat Multiple Myeloma Moderators: Dr. Saidjalal Baxramov, Dr. Rauf Haznedar, Dr. Levent Undar Which is Best and Most Convenient Treatment of 12:45-13:15 Relapsed and Refractory Cases in Multiple Myeloma Dr. Michel Delforge 13:15-13:45 New Drugs in Multiple Myeloma Dr. Rafat Abanour 12:15-13:30 Lunch Break Stem Cell Transplant – 2 Moderators: Dr. Sevgi Kalayoglu Besisik, Dr. Bulent Eser, Dr. Gulyuz Ozturk 13:45-14:15 Optimizing Treatment of Multiple Myeloma Complications Dr. Evangelos Terpos 14:15-14:45 MRD Monitoring in Multiple Myeloma: Where are We Now? Dr. Bruno Paiva 14:45-15:00 Open Coffee Break and Discussion with the Speakers Moderators: Dr. Turker Cetin, Dr. Ali Kosar, Dr. İsmail Sari 15:30-16:00 Diagnosis and Management of Peri-Operative Risk (Bleeding and Thrombosis) Discussing IFI Management with the Guideline in FEN Patients 16:00-16:30 How to Manage Aplastic Anemia Without SCT 16:30-17:00 Rational Drug Use and Pharmaceutical Industry Dr. Arnon Nagler 14:00-14:30 Advances in Mobilization Failure Dr. Nabih Azar 14:30-15:00 Specific Lectures 15:00-15:30 13:30-14:00 Haploidentical Stem Cell Transplant Cord Blood Transplant: A Reliable Alternative for Elderly Patients? Dr. Daniela Cilloni Closing Ceremony Dr. Burak Uz Prof. Giuseppe Saglio, Prof. Suleyman Dinçer, Prof. Birol Guvenc Dr. Livio Pagano Dr. Ali Unal S. Tugba Koc 9 Ataturk Bulvarı 169/40 Bakanlıklar - Ankara / Turkey Phone: +90 312 425 79 52 • Fax: +90 312 425 79 41 www.hematology.org.tr 10 IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS PROGRAM 09-13 OCTOBER 2013 10 October 2013 Thursday Complications and Hematologic Infections Sessions Moderator: Dr. Sema Anak, Dr. Ali Unal, Dr. Gulyuz Ozturk 09:00-09:30 New Antibiotic Strategy in Neutropenia 09 October 2013 Wednesday 16:00-16:30 Opening Speech The Patient at the Centre of IFI Management: Putting Theory Into Practice Profilactic Anti Fungal Treatment in Hematologic 10:00-10:30 Malignancies 09:30-10:00 Dr. Suleyman Dincer The Opening Session of the Congress Moderator: Dr. Giuseppe Saglio, Dr. Birol Guvenc Treatment of Acute Myeloid Leukemia: Are We Making 16:30-17:00 Dr. Alan Burnett Progress? New Strategies With Minimal Residual Disease and 17:00-17:30 Dr. Dieter Hoelzer Targeted Therapy in Adult Acute Lymphoblastic Leukemia 17:30-18:00 Debate: HL Therapy in 2013: Possible Approaches Dr. Alessandro Levis 18:00-18:30 Iron Overload in MDS Dr. Eliezer Rachmilewitz 18:30-19:00 Cancer Stem Cells: An Update Dr. Albert Donnenberg Dr. Omrum Uzun Dr. Samir Agrawal Dr. Esin Senol 10:30-10:45 Coffee Break MPN Moderator: Dr. Aysen Timuragaoglu, Dr. Cengiz Beyan 10.45-11:15 Molecular Genetics of MPNs Dr. Daniela Cilloni 11:15-11:45 Therapeutic Advances in MPN Dr. Selim Yavuz 11:45-12:15 Transplantation in MPN Dr. Francesco Frassoni Evidence based management of Essential 12:15-12:45 Thrombocythemia Dr. Petro E. Petrides 12:45-13:30 Lunch Break 19:00 Opening Cocktail ALL Moderator: Dr. Serdar Bedii Omay, Dr. Mustafa Solak, Dr. Hakan Goker 13:30-14:00 Moleculer Genetics of ALL Dr. Sabina Chiaretti Dr. Mohamed Said Yousuf Ahmed Transplantation in ALL Acute Lymphoblastic Leukemia in Dr. Mohamed Said Yousuf 14:30-15:00 Adolescents Between Pediatric and Adult Camps Ahmed 14:00-14:30 Ph+ ALL New Era 15:00-15:15 Coffee Break MDS Moderator: Dr. Peter Greenberg, Dr. Ali Kosar, Dr. Sehmuz Ertop Recent Clinical and Molecular Advances in the 15:15-15:45 Management of MDS Patients 15:45-16:15 New Drugs in MDS Treatment In Elderly Patients With AML Which Patients Should be Considered Fit or Unfit for Standart Induction Therapy? Myelodysplastic Syndromes: Who and When Should be 16:45-17:15 Transplanted in the Disease Process? CML Moderator: Dr. Giuseppe Saglio, Dr. Hakan Ozdogu 16:15-16:45 17:15-17:45 CML Successful Targeted Therapy “The congress’s organization were made by Hematology Specialists Association.” 17:45-18:15 Dr. Berksoy Sahin In DLBL’s Treatment When Autogous and When Allogenic Therapy Will Apply? Dr. Guray Saydam Iron Overload Moderator: Dr. Maria Domenica Cappellini, Dr. Salih Aksu Dr. Maria Domenica Cappellini Methods to quantify Iron Overload. How reliable is ferritin Dr. Antonio Piga plasmatic concentration? Stem Cell Transplantation and Gene Therapy in the 10:00-10:30 Dr. Emanuele Angelucci B-Hemoglobinopathies 09:00-09:30 How I treat my hemoglobinopathy patients? 09:30-10:00 10:30-10:45 Coffee Break 11:15-11:45 APL: A Curable Leukemia Without Chemotherapy Dr. Alessandro Levis 11:45-12:15 Dr. Evren Ozdemir 12:45-13:30 Lunch Break STC Moderator: Dr. Suleyman Dincer, Dr. Saidjalal Bakhramov, Dr. Abdulhalim Raimjanov 13:30-14:00 Advances in Mobilization Failure Dr. Nabih Azar 14:00-14:30 Autologous BMT Dr. Alev Erikci 14:30-15:00 Bone Marrow Transplantation: Haploidentical Transplantation Dr. Mustafa Cetin 15:00-15:15 Coffee Break Multiple Myeloma Moderator: Dr. Orhan Ayyildiz, Dr. Deniz Sargin, Dr. Filiz Vural How to Use New Biology to Guide Therapy in Multiple 15:15-15:45 Myeloma The Treatment of Posttransplantation in Multiple 15:45-16:15 Myeloma: Minimal Residual Disease Control Doublets, Triplets, or Quadruplets of Novel Agents in Newly 16:15-16:45 Diagnosed Myeloma? Dr. Francesco Frassoni AML Moderator: Dr. Melek Koksal Erkisi, Dr. Nilgun Sayinalp, Dr. Mustafa Cetiner Aplastic Anemia: Therapeutic Updates in 10:45-11:15 Dr. Emanuele Angelucci Immunosuppression and Transplantation High Grade Lymphomas Moderator: Dr. Mehmet Turgut, Dr. Bulent Eser, Dr. Ismail Sari 12:15-12:45 Dr. Mehmet Ali Ozcan 12 October 2013 Saturday 11:00-11:15 Coffee Break 11:45-12:15 Therapy of DLCLs Dr. Florian Nolte Is Going For Cure in Chronic Myeloid Leukemia Possible Dr. Giuseppe Saglio and Justifiable? 11 October 2013 Friday CLL and Indolent Lymphomas Moderator: Dr. Emili Montserrat, Dr. Oktay Faradjev, Dr. Duzgun Ozatli Implications of New Prognostic Markers in Chronic 09:00-09:30 Dr. Emili Montserrat Lymphocytic Leukemia Emerging Role of Kinase-Targeted Strategies in Chronic 09:30-10:00 Dr. Paolo Ghia Lymphocytic Leukemia In The Hematological Malignancies, Minimal Residual Disease 10:00-10:30 Dr. Nikolai Tupitsyn Criteria During the First Diagnose 10:30-11:00 Low Grade Lymphoma Treatment Strategy Dr. Peter Greenberg Minimal Residual Disease in Acute Myeloid Leukemis: Coming of Age Dr. Erdal Kurtoglu Dr. Mehmet Yilmaz 12:15-13:00 Lunch Break CML Moderator: Dr. Suleyman Dincer, Dr. Hakan Ozdogu Monitoring Disease Response in Chronic-Phase Chronic 13:00-13:30 Myloid Leukemia: The Age of Moleculer Assays? What Place for FISH Analysis in CML Special Topics Moderator: Dr. Yurdanur Kilinc, Dr. Turker Cetin, Dr. Atilla Tanyeli Dr. Elias Jabbour 13:30-14:00 PNH, Atypical HUS Dr. Mustafa Nuri Yenerel 14:00-14:30 ITP, New Treatment Strategy Dr. Fahri Sahin 14:30-14:45 Coffee Break Poster Awards and Presentations Moderator: Dr. Birol Guvenc, Dr. Guray Saydam Dr. Michel Delforge 14:45-15:45 Poster Awards and Presentations Dr. Sergey Samanskiy Special Topics Moderator: Dr. Ahmet Faik Oner, Dr. Bulent Zulfikar, Dr. Armen Gasparyan Dr. Rafat Abanour 15:45-16:15 Hemophilia, Outcome and Complication Dr. Alphan Kupesiz 16:15-16:45 Basic Plasma Fractionation Dr. Zera Tellier 16:45-17:15 Hemophilia Gene Therapy Dr. Bulent Antmen 17:15-18.15 Rational Use of Drugs Dr. Kamil Vural 11 12 SCIENTIFIC PROGRAM 17 October 2012 Wednesday In memory of ATİLLA YALCIN -Special Session16:00-16:30 Opening Speech 18 October 2012 Thursday Iron Overload Suleyman Dincer Presidential Giuseppe Saglio, Birol Guvenc Lectures 09.00-9.30 16:30-17:00 Current therapeutical options for acute myeloid leukemia Alan Burnett 17:00-17:30 How will change stem cell transplantation in the future? Moderators: Ilhan Tezcan, Yurdanur Kilinc, Nazli D. Kaya Richard Champlin 17:30-18:00 The impact of genomics in clinical medicine: Tracing Vera Donnenberg tumor mutational evolution through single cell genomics 18.00 Opening Cocktail Chelation therapy in 2012 Antonio Piga 09.30-10.00 Iron Overload in MDS Eliezer Rachmilewitz 10.00-10.30 Transplantation in thalassemia patients Gulyuz Ozturk 10.30-10.45 Coffee Break Myeloproliferative Disorders Moderators: Osman Özcebe, Ali Keskin, Hakan Ozdogu 10.45-11.15 The complex biology of myeloproliferative disorders 11.15-11.45 Conventional therapy of MPDs: When SCT maybe indicated? 11.45-12.15 Molecular targeted therapy of MPDs Selim Yavuz Selim Yavuz Mustafa Cetiner 12.30-13.30 Lunch Myelodysplastic Syndromes Moderators: Ali Unal, Bulent Eser 13.30-14.00 Biological and clinical heterogeneity of MDS Giuseppe Saglio 14.00-14.30 Current classification and risk scoring in MDS Mehmet Ali Ozcan 14.30-15.00 Hypomethylation and hypomethylating agents in MDS Aysen Timuragaoglu 15.00-15.15 Coffee Break Acute Lymphoblastic Leukemia Moderators: Atilla Tanyeli, Yuri Chervonobab 15.15-15.45 Adult ALL therapy in 2012 Dieter Hoeltzer 15.45-16.15 Pediatric ALL therapy in 2012 Bulent Antmen Chronic Myeloid Leukemia Moderators: Cengiz Beyan, Salih Aksu 16.15-16.45 Present approaches to CML therapy in 2012 Naeem Chaudhri 16.45-17.15 Monitoring response of CML patients Guray Saydam 17.15-17.45 19 October 2012 Friday 20 October 2012 Saturday Practical Approaches in Apheresis and Transfusion Current diagnostic stratification of CLL patients Costas Stamatopoulos 09.30-10.00 Current therapy approaches for CLL Emili Montserrat 10.00-10.30 Present approaches for indolent lymphomas Berksoy Sahin 10.30-10.45 Coffee Break High Grade Lymphomas Moderators: Ali Kosar, Osman İlhan Diagnosis and risk stratification of high grade lymphomas Chemotherapy-antibodies stem cell transplantation? 11.15-12.30 How can we better combine all these approaches for high-grade lymphomas? 10.45-11.15 12.30-13.00 Hodgkin Lymphoma Filiz Vural Burhan Ferhanoglu Alessandro Levis 13.00-14.00 Lunch Multiple Myeloma Conventional therapy of MM therapy in young and elderly patients Ismet Aydogdu Raphael Fonseca Optimization of Bortezomib Treatment in Multiple 15.00-15.30 Myeloma Michel Delforge 15.30-15:45 Coffee Break Stem Cell Transplantation Moderators: Oktay Faradjov, Nikolai Tupitsyn, Vahap Okan Fungal infections in the immune-compromised patients: Which prevention? Which therapy? Bacterial and viral infections in the immune16:45-17:15 compromised patients: Which prevention? Which therapy? 16:15-16:45 09:30-09:45 Bening Hematology in Uzbekistan Current therapeutic options for low-grade malignant 09:45-10:00 lymphomas How to setup a modern blood bank? Equipment, 10.00-10:30 personnel and management 10.30-10.45 Coffee Break Ferda Tekinturhan Abdulhalim Rahimjanov Saidcalal Bahramov Oktay Faradjov Turker Cetin Transplantation Moderators: Suleyman Dincer, Deniz Sargin, Hamid Karimov 10.45-11.15 When RIC should be preferred in SCT? Haploidentical or cord blood stem cells; which and 11.15-11.45 when? 11.45-12.15 Management of graft-versus host disease in 2012 Richard Champlin Hakan Goker Ahmet Ifram Special Topics 14.30-15.00 When proteasome inhibitors in the therapy of MM? 15:45-16:15 Therapeutic use of non hematopoietic stem cells Moderators: Ercument Ovali, Nilgün Sayinalp Country-based experiences in apheresis, transfusion, 09.00-09:15 stem cell collection and processing 09:15-09:30 Transplantation in Kirghizstan 12.30-13.30 Lunch Moderators:Rauf Haznedar, Orhan Ayyildiz 14.00-14.30 Giuseppe Saglio Chronic Lymphocytic Leukemia and Indolent Lymphomas Moderators: Şehmuz Ertop, Hasan Kaya 09.00-9.30 What have we learned from CML that are useful for other hematologic malignancies? Albert Donnenberg Sesin Kocagöz Gokhan Metan Moderators: Mustafa Solak, Oktay Faradjov, Bulent Zulfukar The benefits of prophylaxis from early age till adulthood 13.30-14.00 in persons with hemophilia Diseases and diagnosis of paroxysmal nocturnal 14.00-14.30 hemoglobinuria Current approaches for paroxysmal nocturnal 14:30-15:00 hemoglobinuria – medical case treatment Thrombotic microangiopathy: Current knowledge and 15:00-15:30 outcomes with plasma exchange 15:30-15:45 Coffee Break Jan Blanty Ozlem Balcik Fuat Oduncu Joseph Kiss Special Topics Moderators: Ahmet Ozturk, Mehmet Turgut Importance of genetic classification in the management 15:45-16:15 of AML 16:15-16:45 Best induction therapy in AML Mustafa Yenerel 16:45-17:15 Which AML patients should be transplanted? Sevgi Kalayoglu Besisik 17.15-17.45 Atypical HUS Sibel Kabukcu 17:45-18:15 Rational use of medicines Birol Guvenc Mehmet Yilmaz 13 14 BİLİMSEL PROGRAM 13 Ekim 2011 Perşembe Oturum Başkanları: Prof. Dr. Mustafa Solak - Prof. Dr. Ayşen Timurağaoğlu 16:00-16:30 Açılış Konuşması Prof. Dr. Süleyman Dinçer 17:00-17:30 Kanser Kök Hücresi Prof. Dr. Vera Donnenberg 16:30-17:00 Terapötik Kök Hücre Kaynakları 17:30 Açılış Kokteyli Prof. Dr. Albert Donnenberg 09:30-10:00 Pediyatrik Kök Hücre Transplantasyonu Prof. Dr. Gülyüz Öztürk Allojenik Kök Hücre Naklinde Profilaktif Prof. Dr. Hakan Özdoğu Tedaviler 10:30-10:45 Kahve Arası Salon A: 2. Oturum: Oturum Başkanları: Prof. Dr. Cengiz Beyan - Prof. Dr. Ali Ünal Oleg Rukavitsyn 10.45-11:15 GVHD ve Yeni Tedavi Yaklaşımları Prof. Dr. Seçkin Çagırgan 11:15-11:45 IDSA 2011 Klavuzu Doç. Dr. Mustafa Pehlivan Fungal Enfeksiyonların Tedavisinde Son 11:45-12:15 Prof. Dr. Yeşim Taşova Gelişmeler Uydu Sempozyumu: Multipl Miyelomda Tedavi Optimizasyonu (Janssen-Cilag) Oturum Başkanı: Prof. Dr. Meral Beksaç 12:15-13:30 Yeni Tanı Multipl Miyelom: Hasta Yönetimi Prof. Dr. Sevgi Kalayoğlu Beşışık Relaps Refrakter Multipl Miyelomlu Hastaya Prof. Dr. Rıdvan Ali Yaklaşım 10:00-10:30 14 Ekim 2011 Cuma Açılış Seramonisi Salon A: 1. Oturum: Oturum Başkanları: Prof. Dr. İbrahim Haznedar - Prof. Dr. Sema Anak Prof. Dr. Birol Güvenç 09:00-09:30 KML’de Güncel Tedavi Prof. Dr. Giuseppe Saglio 09:30-10:00 KML’de Monitörizasyon Prof. Dr. Giovanna Rege-Cambrin Yeni TKI’leri Birinci Basamakta 10:00-10:30 Prof. Dr. Philipp Le Coutre Kullanılmalı Mı? 10:30-10:45 Kahve Arası Salon A: 2. Oturum: Oturum Başkanları: Prof. Dr. Rauf Haznedar - Prof. Dr. Hakan Göker Gunta Purkale KML Dışındaki Myeloproliferatif Hastalıklar ve Prof. Dr. Berksoy Şahin Yeni Tedavi Olasılıkları 11:15-11:45 Türkiyede MM’nın Tedavisi ve Güncel Sorunlar Prof. Dr. Meral Beksaç 11:45-12:15 Multipl Miyelom’da Yeni Tedavi Algoritmaları Prof. Dr. Deniz Sargın Uydu Sempozyumu: AML ve MDS Hastalarında Yeni Tedavi Yaklaşımları ve 12:15-13:30 Sağkalım (Erkim) AML Prof. Dr. Ayşen Timurağaoğlu MDS Prof. Dr. Mehmet Ali Özcan 13:30-14:00 Öğle Arası Salon A: 3. Oturum: Oturum Başkanları: Prof. Dr. Serdar Bedii Omay - Prof. Dr. Sait Celal Bahramov Celalov - Ismailzade Reiman 14:00-14:30 PNH: Yeni Tanı Seçenekleri Prof. Dr. Bülent Antmen 14:30-15:00 PNH: Klinik ve Yeni Tedavi Yaklaşımları Prof. Dr. Birol Güvenç 15:00-15:30 MDS Yönetiminde Yeni Yaklaşımlar Prof. Dr. Norbert Gattermann 15:30-15:45 Kahve Arası Salon A: 4. Oturum: Oturum Başkanları: Prof. Dr. Orhan Ayyıldız - Doç. Dr. Evren Özdemir Yuri Chervonobab 15:45-16:15 Relaps/Refraktör AML Hastalarında Tedavi Doç. Dr. Mustafa Çetiner HUD Hematoloji Vizyonu 16:15-16:45 HUD Derneğinin Vizyon ve Misyonu Prof. Dr. Birol Güvenç HUD ve Bilişim Teknolojileri Pleksus Bilişim Teknolojileri 16:45-17:15 Endüstrinin Hematoloji Vizyonu* Alexion, BMS 17:15-19:00 Endüstrinin Hematoloji Vizyonu* Celgene, Eczacıbaşı-Baxter, Erkim, Jansen-Cilag, Novartis, Roche *Konuşmalar alfabetik sıralamaya göre düzenlenmiştir. 21:00 GALA GECESİ 10.45-11:15 15 Ekim 2011 Cumartesi Salon A: 1. Oturum: Oturum Başkanları: Prof. Dr. Atilla Tanyeli - Prof.Dr. Süleyman Dinçer Mamia Zodelava Hematolojik Kök Hücre Transplantasyonunda 09:00-09:30 Prof. Dr. Ali Uğur Ural Güncel ve Yeni Tedavi Yaklaşımları 13:30-14:00 Öğle Arası Salon A: 3. Oturum: Oturum Başkanları: Prof. Dr. Mahmut Bayık - Prof. Dr. Ahmet Öztürk Oktay Farajov Foliküler Lenfomada Erken ve Geç Evredeki 14:00-14:30 Prof. Dr. Claire Harrison Hastalarda Optimal Tedavi KLL Tedavisinin Bugünü ve Gelecek Tedaviler, 14:30-15:00 Transplantasyonun Yeri 15:00-15:30 Ph (+) ALL’de Tedavi Yaklaşımları 15:30-15:45 Kahve Arası Salon A: 4. Oturum: Oturum Başkanları: Prof. Dr. Osman Abdukhalım Raımzhanov Rejeneratif Tıp Uygulamaları Bugün ve 15:45-16:15 Gelecek 16:15-16:45 Aferez Teknolojisi Nereye Gidiyor? 16:45-17:15 Kan Bankacığı Nereye Gidiyor? 17:15Avrasya Hematoloji Ortak Çalışmaları Oktay Farajov Saidcelal Bakramoc Mamia Zodeleva Slobodan Loncarevic Svetlena Sultan Gaziyeva Prof. Dr. Zafer Gülbaş Doç. Dr. Fahri Şahin Özcebe - Prof. Dr. Türker Çetin Prof. Dr. Ercüment Ovalı Uzm. Bio. Ferda Tekinturhan Hızır Uzuner Azerbaycan Özbekistan Gürcistan Gürcistan Kazakistan Rusya Letonya, Estonya, Kırgızistan, Suriye, Kırım, Bosna Hersek, Ukrayna, Tacikistan, Filistin, Afganistan 15 16 SCIENTIFIC PROGRAM THURSDAY, OCTOBER 7, 2010 Room A 13.00 - 13.30 Opening Room B SATURDAY, OCTOBER 9, 2010 Room A Room B EDUCATORS EDUCATION CONFERANCES BASIC HEMATOLOGY EDUCATION CONFERENCES 08.30 - 10.00 ANEMIAS Hemolytic Anemias Acquired Congenital 13.30 - 14.30 AML Diagnosis and Treatment Hematopoiesis Evaluation of Hemogram 10.00 - 10.20 Coffee Break Platelet Disease ALL Diagnosis and Treatment Evaluation of Peripheral Smear Basic Laboratory Tests in Hematology 10.20 - 11.20 14.30 - 15.30 A Special Branch: Hematology Nursing The First Diagnosis of Cancer 15.30 - 15.50 Coffee Break 11.20 - 12.20 Satellite Symposium 15.50 - 16.50 CML Diagnosis and Treatment Psychosocial Problems in Patients with Hematological Oncology Hematology KIT The Role of Nurses in Preparation and Use of Chemotherapeutic Agents 12.20 - 13.30 Lunch 16.50 - 17.50 CLL Diagnosis and Treatment 13.30 - 14.30 Coagulabilities 14.30 - 15.30 Satellite Symposium 15.30 - 15.50 Coffee Break Diagnosis Methods in Hematology Flow Cytogenetics Visualization 19.00 Opening Cocktail FRIDAY, OCTOBER 8, 2010 Room A 08.30 - 09.00 09.00 - 09.30 09.30 - 10.00 Lymphoma HL NHL 10.00 - 10.20 Coffee Break Approach to Patients with Anemia Approach to Patients with Leukopenia/ Leukocytosis Approach to Patients with Trombocytopenia Management of LAP Room B TRANSFUSION What is Therapeutic Apheresis? Blood Products and Indications Transfusion Complications 10.20 - 11.20 FREQUENT ANEMIAS MM Diagnosis and Treatment Iron Deficiency Anemia and Treatment Megaloblastic Anemia and Treatment 11.20 - 12.20 MDS Diagnosis and Treatment 12.20 - 13.30 Lunch 13.30 - 14.30 Transplantation 14.30 - 15.30 Supportive Therapy 15.30 - 15.50 Coffee Break 15.50 - 17.00 Aplastic Anemia PNH 17.00 - 18.00 Stem Cell Tratment APPROACH TO HEMOLYTIC ANEMIA Immune Hemolytic Anemias Non-Immune Hemolytic Anemias APPROACH TO COAGULATION DISORDERS Approach to and Follow-Up of Patients With Hemophilia Approach to and Follow-Up of Patients With Thrombophilia APPROACH TO HEMOGLOBINOPATHIES Approach to Patients With Thalassemia Approach to Patients With Sickle Cell 15.50 - 17.30 20.00 QUIZ The Two Complications Discussed in the Treatment of Cancer, Extravasation and Hypersensitivity Oral and Dental Health of Hematology Patients Patients in the Terminal Period and Supportive Care Life Quality of Hematology Patients Patient and Family Education Ethical and Legal Issues Related to Cancer Treatment Gala Dinner SUNDAY, OCTOBER 10, 2010 09.00 - 10.30 Oral Presentations 10.30 - 11.30 Meeting with Industry 11.30 Board Meeting APPROACH TO CANCER PATIENTS Supportive Treatment of Cancer Patients DISCUSSION Ask to Expert 17 Educational Activities Eurasian Hematology Summit 23 April 2014, Shangri- La Bosphorus / Istanbul Atypical Hemolytic Uremic Syndrome Meeting 22 March 2014, Masel Hotel / Adana Paroxysmal Nocturnal Hemoglobinuria (PNH) Meeting 14 March 2014, Hilton Hotel / Diyarbakır Paroxysmal Nocturnal Hemoglobinuria (PNH) Roundtable Meeting 22 December 2012, Masel Hotel / Adana Eurasian Stem Cell and Apheresis Symposium 05-08 May 2011, The Marmara Hotel / Antalya 18 19 20 Hematology Specialist Association Ataturk Bulvari 169/40 Bakanliklar/Ankara/Turkey Phone: +90 312 4257952 • Fax: +90 312 4257941 E-mail: [email protected] • www.hematoloji.org.tr EURASIAN HEMATOLOGY FORUM ISTANBUL PROGRAM 09:15 Dear Collegues, Opening Speech Prof. Suleyman Dincer Moderator: Prof. Giuseppe Saglio As a Hematology Specialists Association with the aim to provide more scientific platforms for hematologist, we are honored to present our new joint project together with MD Anderson Department of Leukemia MPN 09:30-10:00 What is New in MPN Prof. Elias Jabbour Eurasian Hematology Forum. AML There will be Presentations and Discussion section on the topics MPN, 10:10-10:40 What is New in AML Prof. Hagop M. Kantarjian ALL, AML, MDS, CML, CLL. Discussion section will make our Forum more efficient and let all the participants to share their points of view. 10:50-11:10 Coffee Break ALL We are pleased to announce that Eurasian Hematology Forum will be held in Shangri-la Bosphorus Hotel, Istanbul, on April, 23, 2014. 11:10-11:40 What is New in ALL Prof. Susan O’Brien MDS 11:50-12:20 What is New in MDS Prof. Guillermo Garcia Manero 12:30-13:30 Lunch Break Moderator: Prof. Birol Guvenc CML 13:30-14:00 Frontline Therapy Prof. Suleyman Dincer Hematology Specialists Association President Prof. Birol Guvenc Hematology Specialists Association General Secretary Prof. Giuseppe Saglio The President of the Meeting 14:10-14:40 Prof. Hagop M. Kantarjian Milestones and Resistance CLL 14:50-15:20 What is New in CLL Prof. Elias Jabbour Prof. Susan O’Brien 15:30-15:50 Coffee Break 21 HEMATOLOGY SPECIALISTS ASSOCIATION Ataturk Bulvarı 169/40 Bakanlıklar - Ankara / Turkey Phone: +90 312 425 79 52 • Fax: +90 312 425 79 41 www.hematology.org.tr • [email protected]